New study: PSMA PET scans may forecast prostate cancer therapy response

NCT ID NCT07089550

Recruiting now Knowledge-focused Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether PSMA PET scans can predict how well advanced prostate cancer patients will respond to treatments like hormone therapy or chemotherapy. Researchers will scan 1300 patients before they start treatment and track their outcomes. The goal is to find imaging markers that help doctors choose the best therapy for each person.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PSMA PET/CT scan (radiation-based imaging)
What this could lead to: If successful, this could help doctors predict which treatments work best for advanced prostate cancer patients, leading to more personalized care.
What could go wrong: This is an observational study, not a treatment trial. It may not change outcomes directly, and results might not apply to all patients or therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic prostate carcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER METASTATIC PSMA POSITIVE TUMORS OR TUMOR TISSUES

Contacts and locations

Locations

Azienda Ospedaliera Santa Croce e Carle - ospedale Santa Croce
RECRUITING

Cuneo, Italy, 12100, Italy
Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna
RECRUITING

Bologna, Italy, 40138, Italy
U.O. Medicina Nucleare, IRCCS Ospedale Policlinico San Martino
RECRUITING

Genova, Italy, 16131, Italy
UOC Medicina Nucleare, AOU Policlinico G.Martino
RECRUITING

Messina, Italy, 98125, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.